We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Impinj
PI
$5.6B
| $1.1M | ﹤0.01% |
19,333
-1,862
| -9% | -$110K |
|
|
MRSN
2152
DELISTED
Mersana Therapeutics
MRSN
| $1.1M | ﹤0.01% |
2,715
-87
| -3% | -$42.2K |
|
|
ATRS
2153
DELISTED
Antares Pharma, Inc.
ATRS
| $1.1M | ﹤0.01% |
267,136
-13,680
| -5% | -$59.3K |
|
2154
Ducommun
DCO
$2.98B
| $1.09M | ﹤0.01% |
18,230
-750
| -4% | -$41.9K |
|
|
FBMS
2155
DELISTED
The First Bancshares, Inc.
FBMS
| $1.09M | ﹤0.01% |
29,721
-18,885
| -39% | -$634K |
|
|
MSGN
2156
DELISTED
MSG Networks Inc.
MSGN
| $1.08M | ﹤0.01% |
72,003
-7,551
| -9% | -$126K |
|
|
ADVM
2157
DELISTED
Adverum Biotechnologies
ADVM
| $1.08M | ﹤0.01% |
10,945
-879
| -7% | -$106K |
|
|
YMAB
2158
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.08M | ﹤0.01% |
35,696
-2,800
| -7% | -$115K |
|
|
TRTX
2159
TPG RE Finance Trust
TRTX
$618M
| $1.08M | ﹤0.01% |
96,263
-53,239
| -36% | -$583K |
|
2160
Petco
WOOF
$794M
| $1.08M | ﹤0.01% |
+48,552
| New | +$1.16M |
|
|
ALTA
2161
DELISTED
Altabancorp
ALTA
| $1.07M | ﹤0.01% |
25,444
-1,325
| -5% | -$46.7K |
|
2162
Alpha and Omega Semiconductor
AOSL
$1.08B
| $1.07M | ﹤0.01% |
32,668
-1,500
| -4% | -$49.3K |
|
|
NWLI
2163
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.07M | ﹤0.01% |
4,291
-198
| -4% | -$42.5K |
|
2164
Green Brick Partners
GRBK
$3.14B
| $1.06M | ﹤0.01% |
46,966
+2,740
| +6% | +$58.4K |
|
|
GOOD
2165
Gladstone Commercial Corp
GOOD
$627M
| $1.06M | ﹤0.01% |
54,248
-3,924
| -7% | -$74.2K |
|
2166
Mercer International
MERC
$39.8M
| $1.06M | ﹤0.01% |
73,754
+5,556
| +8% | +$74K |
|
2167
Atea Pharmaceuticals
AVIR
$420M
| $1.06M | ﹤0.01% |
17,163
+4,647
| +37% | +$314K |
|
|
CELL
2168
DELISTED
PhenomeX Inc. Common Stock
CELL
| $1.06M | ﹤0.01% |
21,062
+11,819
| +128% | +$806K |
|
|
HTBK
2169
DELISTED
Heritage Commerce
HTBK
| $1.06M | ﹤0.01% |
86,439
-5,650
| -6% | -$56.5K |
|
2170
Talos Energy
TALO
$2.4B
| $1.05M | ﹤0.01% |
87,502
+17,456
| +25% | +$188K |
|
2171
BrightView Holdings
BV
$1.07B
| $1.05M | ﹤0.01% |
62,348
-3,005
| -5% | -$48.1K |
|
2172
Powell Industries
POWL
$7.71B
| $1.04M | ﹤0.01% |
92,259
+855
| +0.9% | +$9K |
|
2173
Energy Fuels
UUUU
$3.53B
| $1.04M | ﹤0.01% |
183,386
-2,701
| -1% | -$13.8K |
|
|
AMTI
2174
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $1.04M | ﹤0.01% |
23,687
+10,119
| +75% | +$492K |
|
2175
RPC Inc
RES
$1.3B
| $1.04M | ﹤0.01% |
192,511
+2,768
| +1% | +$14K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.